The basic science of platelet-rich plasma (PRP): What clinicians need to know

Sports Medicine and Arthroscopy Review

Volumn 21, Issue 4, 2013, Pages 180-185

  Arnoczky, Steven P ^a   Shebani Rad, Shahin ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

bioactive factors; fibrin matrices; platelet rich plasma; thrombin; white blood cells

Indexed keywords

CALCIUM CHLORIDE; FIBRIN; GROWTH FACTOR; SECRETORY PROTEIN; THROMBIN;

BLOOD COMPONENT; BLOOD VOLUME; FIBRIN FORMATION; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING;

ATHLETIC INJURIES; BIOLOGICAL MARKERS; FIBRIN; GUIDED TISSUE REGENERATION; HUMANS; LEUKOCYTES; PLATELET-RICH PLASMA; THROMBIN; TISSUE SCAFFOLDS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84888244456     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0b013e3182999712     Document Type: Review

References (54)

1. Clark RAF. The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York: Plenum press; 1996
2. Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Rep Reg. 2008;16:585-601
3. Greenhalgh DG. The role of growth factors in wound healing. J Trauma. 1996;41:159-167
4. Guo S, DePietro LA. Factors affecting wound healing. J Dent Res. 2010;89:219-229
5. Toumi H, Best TM. The inflammatory response: Friend or enemy for muscle injury? Br J Sports Med. 2003;37:284-286
6. Blair P, Flaumenhaft R. Platelet a-granules: Basic biology and clinical correlates. Blood Rev. 2009;23:177-189
7. Leslie M. Beyond clotting: The power of platelets. Science. 2010;328:562-564
8. Arnoczky SP, Delos D, Rodeo SA. What is platelet-rich plasmäOper Tech Sports Med. 2011;19:142-148
9. Kingsley CS. Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma. Nature. 1954;173: 723-724
10. Sampson S, Gerhardt M, Mandelbaum B. Platelet-rich plasma injection grafts for musculoskeletal injuries: A review. Curr Rev Musculoskelet Med. 2008;1:165-174
11. Lopez-Vidriero E, Goulding KA, Simon DA, et al. The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy. 2010;26: 269-278
12. Gullotta LV, Rodeo SA. Growth factors for rotator cuff repair. Clin Sports Med. 2009;28:13-23
13. Vavaken P, Saad FA, Murray MM. Age dependence of expression of growth factor receptors in porcine ACL fibroblasts. J Orthop Res. 2010;28:1107-1112
14. Sprugel KH, McPherson JM, Clowes AW, et al. Effects of growth factors in vivo. Am J Path. 1987;129:601-613
15. Castillo TN, Pouliot MA, Kim HJ, et al. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39:266-271
16. deVos RJ, Weir A, van Schie H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA. 2010;303:144-149
17. Marx RE. Platelet-rich plasma (PRP). What is PRP and what is not PRP? Implant Dent. 2001;10:225-228
18. Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34:665-671
19. Bird RB, Stewart W, Lightfoot EN. Transport Phenomena. 2nd ed. Hoboken, NJ: J Wiley and Sons; 2007
20. Steine-Martin EA, Lotspeich-Steininger CA, Koepke JA. Clinical Hematology: Principles, Procedures, Correlations. 2nd ed. Philadelphia, PA: Lippincott Williams &Wilkins; 1998
21. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158-167
22. Mei-Dan O, Mann G, Maffulli N. Platelet-rich plasma: Any substance to it? Br J Sports Med. 2010;44:618-619
23. Leitner GC, Gruber R, Neumuller J, et al. Platelet content and growth factor release in platelet-rich plasma: A comparison of four different systems. Vox Sang. 2006;91:135-139
24. Mazzucco L, Balbo V, Cattana E, et al. Not every PRP-gel is born equal: Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinets, RegenPRPKits, Plateltexs, and one manual procedure. Vox Sang. 2009;97:110-118
25. Sheth U, Simunovic N, Klein G, et al. M: Efficacy of autologous platelet-rich plasma use for orthopaedic indications: A meta-analysis. J Bone Joint Surg Am. 2012;94:298-307
26. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: The PAW classification system. Arthroscopy. 2012;28:998-1009
27. Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med. 2009;37:2259-2272
28. Mooren R, Hendriks EJ, van der Beuken J, et al. The effect of platelet-rich plasma in vitro on primary cells: Rat osteoblast-like cells and human endothelial cells. Tissue Eng Part A. 2010;16: 3159-3172
29. Alberts B, Bray D, Lewis J, et al. Molecular Biology of the Cell. 3rd ed. New York: Garland Publishing Inc.; 1994
30. Ranly DM,McMillan J, Keller T, et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunecompromised mice. J Bone Joint Surg Am. 2005;87:2052-2064
31. Mishra A, Randelli P, Barr C, et al. Platelet-rich plasma and the upper extremity. Hand Clin. 2012;28:481-491
32. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94:e143, (1-8
33. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost. 1999;82:165-174
34. Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery. J Bone Joint Surg Am. 2009;91-B:987-996
35. Bielecki TM, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br. 2007;89:417-420
36. Cieslik-Bielecka A, Bielecki T, Gazdzik TS, et al. Autologous platelets and leukocytes can improve healing of infected highenergy soft tissue injury. Transfus Apher Sci. 2009;41:9-12
37. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL- 6) levels in the plasma of stored platelet concentrates: Relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion. 1993;33:195-199
38. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion. 1994;34:20-25
39. AyeMT, Palmer DS, Giulivi A, et al. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion. 1995;35:117-124
40. Palmer DS, Aye MT, Dumont L, et al. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system. Vox Sang. 1998;75:115-123
41. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288:R345-R353
42. Dragoo JL, Braun HJ, Durham JL, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in helathy rabbit tendons. Am J Sports Med. 2012;40:1274-1281
43. Martin P, Leibovich SJ. Inflammatory cells during wound healing: The good, the bad, and the ugly. Trends in Cell Biol. 2005;15:599-607
44. Schneider BS, Tiidus P. Neutrophil infiltration in exerciseinjured muscle: How do we solve the controversy? Sports Med. 2007;37:837-856
45. Ortel TL, Mercer MC, Thames EH, et al. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233:88-96
46. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost. 2006;32:98-110
47. Schoenecker JG, Johnson RK, Lesher AP, et al. Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol. 2001;159:1957-1969
48. Han B, Woodell-May J, Ponticiello M, et al. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am. 2009;91:1459-1770
49. Ahmed TA, Dare EV, Hincke M. Fibrin: A versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev. 2008;14:199-215
50. Macri L, Silverstein D, Clark RA. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev. 2007;59:1366-1381
51. Visser LC, Arnoczky SP, Caballero O, et al. Platelet-rich fibrin constructs elute higher concentrations of TGF-b1 and increase tendon cell proliferation over time when compared to blood clots: A comparative in vitro analysis. Vet Surg. 2010;39: 811-817
52. Lucarelli E, Beretta R, Dozza B, et al. A recently developed bifacial platelet-rich fibrin matrix. Eur Cells Mater. 2010;20: 13-23
53. Anitua E, Sanchez M, Nurden AT, et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227-234
54. O'Connor SM, Impeduglia T, Hessler K, et al. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Rep Reg. 2008;16: 749-756